Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
AstraZeneca
PMV Pharmaceuticals, Inc
Mayo Clinic
Merck Sharp & Dohme LLC
Tizona Therapeutics, Inc
Essen Biotech
Wake Forest University Health Sciences
Transgene
Hummingbird Bioscience
Memorial Sloan Kettering Cancer Center
NuCana plc
Medicenna Therapeutics, Inc.
M.D. Anderson Cancer Center
Providence Health & Services
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
Pliant Therapeutics, Inc.
Eli Lilly and Company
Queen Mary University of London
OHSU Knight Cancer Institute
OncoSec Medical Incorporated
Centre Leon Berard
Odonate Therapeutics, Inc.
Incyte Corporation
ETOP IBCSG Partners Foundation